Lanean...
DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report
5-Fluorouracil remains a foundational component of chemotherapy for solid tumour malignancies. While considered a generally safe and effective chemotherapeutic, 5-fluorouracil has demonstrated severe adverse event rates of up to 30%. Understanding the pharmacokinetics of 5-fluorouracil can improve t...
Gorde:
| Argitaratua izan da: | Pharmaceutics |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6572291/ https://ncbi.nlm.nih.gov/pubmed/31052357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11050199 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|